The Effect of Third Trimester Corticosteroid Therapy on Fetal Doppler Velocimetry in Gestational Hypertension Complicated By Intrauterine Growth Restriction

Hany Maged Abd El Aal, D. Hassan
{"title":"The Effect of Third Trimester Corticosteroid Therapy on Fetal Doppler Velocimetry in Gestational Hypertension Complicated By Intrauterine Growth Restriction","authors":"Hany Maged Abd El Aal, D. Hassan","doi":"10.26502/ogr018","DOIUrl":null,"url":null,"abstract":"Background Althouh there is a great advance in antenatal care, gestational hypertension still one of the major reasons of maternal and neonatal morbidity and mortality. For this reason, early screening of gestational hypertension and fetal growth retardation can permit cautious antenatal monitoring and proper timing of delivery to steer clear of serious complications. Patient and Methods This is a prospective study that included 100 singleton pregnant women with gestational hypertension and complicated with IUGR fetuses who were divided into 2 groups (A and B), each group consists of 50 patients: All patients in group A subjected to fetal Doppler flow indices measurement before corticosteroid administration, and repeated within five days after its administration. Its effect on fetal outcome detected after termination of pregnancy. While women in group B included 50 patients who did not receive corticosteroid therapy. Fetal Doppler flow indices was measured, and after termination of pregnancy effect on fetal outcome was detected as well.  Results There was statistically significant difference between the study group after corticosteroid administration and the control group regarding the mean Doppler indices in the form of (MCA PI-RI, UMA PI-RI and CPR).  MCA shows higher values in study group after corticosteroid administration than the control group (PI 1.52 ± 0.10 and 1.5 ± 0.18 and RI from 0.78 ± 0.12 to 0.76 ± 0.02. While UMA shows lower values in study group after corticosteroid administration than the control group (PI 1.31 ± 0.16 and 1.36 ± 0.08 and RI 0.72 ± 0.01 and 0.73 ± 0.02. CPR also shows higher values in study group after corticosteroid administration than the control group 1.05 ± 0.05 and 1.04 ± 0.05. Conclusion Corticosteroid administration to hypertensive women is associated with improvement of all Doppler indices in the form of elevation of MCA PI & RI and CPR value and decrease of UMA PI & RI values. Although corticosteroid administration was associated with all these Doppler indices enhancement but there was no associated improvement in the number of fetuses born suffering from tachypnea or admitted to NICU when compared to the other group of women who did not receive corticosteroids. Fetuses who was delivered not affected by tachypnea or not admitted to the NICU shows improvement in UMA PI & RI and CPR in comparison to those who were tachypnic and admitted to the NICU. AEDFV and REDFV signs of UMA are critical signs, usually associated with adverse fetal outcome or fetal compromise.","PeriodicalId":74336,"journal":{"name":"Obstetrics and gynecology research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics and gynecology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/ogr018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background Althouh there is a great advance in antenatal care, gestational hypertension still one of the major reasons of maternal and neonatal morbidity and mortality. For this reason, early screening of gestational hypertension and fetal growth retardation can permit cautious antenatal monitoring and proper timing of delivery to steer clear of serious complications. Patient and Methods This is a prospective study that included 100 singleton pregnant women with gestational hypertension and complicated with IUGR fetuses who were divided into 2 groups (A and B), each group consists of 50 patients: All patients in group A subjected to fetal Doppler flow indices measurement before corticosteroid administration, and repeated within five days after its administration. Its effect on fetal outcome detected after termination of pregnancy. While women in group B included 50 patients who did not receive corticosteroid therapy. Fetal Doppler flow indices was measured, and after termination of pregnancy effect on fetal outcome was detected as well.  Results There was statistically significant difference between the study group after corticosteroid administration and the control group regarding the mean Doppler indices in the form of (MCA PI-RI, UMA PI-RI and CPR).  MCA shows higher values in study group after corticosteroid administration than the control group (PI 1.52 ± 0.10 and 1.5 ± 0.18 and RI from 0.78 ± 0.12 to 0.76 ± 0.02. While UMA shows lower values in study group after corticosteroid administration than the control group (PI 1.31 ± 0.16 and 1.36 ± 0.08 and RI 0.72 ± 0.01 and 0.73 ± 0.02. CPR also shows higher values in study group after corticosteroid administration than the control group 1.05 ± 0.05 and 1.04 ± 0.05. Conclusion Corticosteroid administration to hypertensive women is associated with improvement of all Doppler indices in the form of elevation of MCA PI & RI and CPR value and decrease of UMA PI & RI values. Although corticosteroid administration was associated with all these Doppler indices enhancement but there was no associated improvement in the number of fetuses born suffering from tachypnea or admitted to NICU when compared to the other group of women who did not receive corticosteroids. Fetuses who was delivered not affected by tachypnea or not admitted to the NICU shows improvement in UMA PI & RI and CPR in comparison to those who were tachypnic and admitted to the NICU. AEDFV and REDFV signs of UMA are critical signs, usually associated with adverse fetal outcome or fetal compromise.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
妊娠晚期皮质类固醇治疗对妊娠高血压合并宫内生长受限胎儿多普勒速度的影响
背景虽然产前保健有了很大的进步,但妊娠期高血压仍然是孕产妇和新生儿发病率和死亡率的主要原因之一。因此,早期筛查妊娠期高血压和胎儿生长迟缓可以进行谨慎的产前监测和适当的分娩时间,以避免严重的并发症。患者与方法本前瞻性研究纳入100例妊娠期高血压合并IUGR胎儿的单胎妊娠孕妇,分为a、B两组,每组50例:a组患者在给药前均行胎儿多普勒血流指标测定,并在给药后5 d内重复测定。终止妊娠后检测其对胎儿结局的影响。而B组包括50名未接受皮质类固醇治疗的女性。测定胎儿多普勒血流指数,并检测终止妊娠后对胎儿结局的影响。结果皮质类固醇给药后研究组与对照组在MCA PI-RI、UMA PI-RI和CPR形式的平均多普勒指数方面差异有统计学意义。皮质类固醇给药后,研究组MCA值高于对照组(PI为1.52±0.10和1.5±0.18),RI为0.78±0.12至0.76±0.02。而研究组给糖皮质激素后UMA值低于对照组(PI分别为1.31±0.16和1.36±0.08,RI分别为0.72±0.01和0.73±0.02)。使用皮质类固醇后,研究组CPR值高于对照组(1.05±0.05)和对照组(1.04±0.05)。结论给予皮质类固醇与高血压妇女MCA PI、RI和CPR值升高、UMA PI、RI值降低等多普勒指数均有改善关系。尽管皮质类固醇治疗与所有这些多普勒指数增强有关,但与未接受皮质类固醇治疗的另一组妇女相比,出生时患有呼吸急促或入住新生儿重症监护病房的胎儿数量没有相关的改善。分娩时未受呼吸急促影响或未入住NICU的胎儿与那些呼吸急促并入住NICU的胎儿相比,UMA PI和RI和CPR有所改善。UMA的AEDFV和REDFV体征是关键体征,通常与不良胎儿结局或胎儿妥协相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Sex-Specific Dysregulation of Placental Lipid Metabolism in Preeclampsia. Polyclonal Anti-D Antibodies Significantly Reduce the Rate of Miscarriages in Rh(D) positive Women with Recurrent Pregnancy loss. Exosomal Lipid Biomarkers of Oligodendrocyte Pathology to Predict Scoliosis in Children with Cerebral Palsy. Neonatal Effects of Maternal Supplementation with Docosahexaenoic Acid and Lactoferrin on the Fetal Brain and Placenta in a Rabbit Model of Intrauterine Growth Restriction Effect of Forkhead Box Protein 3 Gene Polymorphisms in Recurrent Pregnancy Loss: A meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1